Shankar Gopi bought LRMR

January 17, 2024 · Form 4 insider transaction

Shankar Gopi bought 22,500 shares of Larimar Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
22,500
Price
$0.00
Total value
N/A
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 17, 2024
Filing dateJanuary 19, 2024
Shares owned after27,500
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

View the original Form 4 on SEC EDGAR